Bruce A. Freeman
Amministratore Delegato presso Creegh Pharmaceuticals, Inc.
Profilo
Bruce A.
Freeman is the founder of Complexa, Inc. founded in 2008.
He is currently the President, Chief Executive Officer & Director at Creegh Pharmaceuticals, Inc. and also serves as the Chairman-Department of Pharmacology at the University of Pittsburgh.
Dr. Freeman received his undergraduate and doctorate degrees from the University of California, Riverside.
Posizioni attive di Bruce A. Freeman
Società | Posizione | Inizio |
---|---|---|
University of Pittsburgh | Corporate Officer/Principal | - |
Creegh Pharmaceuticals, Inc.
Creegh Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Creegh Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is headquartered in Pittsburgh, PA. | Amministratore Delegato | - |
Precedenti posizioni note di Bruce A. Freeman
Società | Posizione | Fine |
---|---|---|
Complexa, Inc.
Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | Fondatore | - |
Formazione di Bruce A. Freeman
University of California, Riverside | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Complexa, Inc.
Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | Health Technology |
Creegh Pharmaceuticals, Inc.
Creegh Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Creegh Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is headquartered in Pittsburgh, PA. | Health Technology |
- Borsa valori
- Insiders
- Bruce A. Freeman